[ Back to EurekAlert! ]

Contact: Laura Niles
Laura.E.Niles@nasa.gov
281-244-7069
NASA/Johnson Space Center

Mark Kelly, NASA

Caption: Antibiotic Effectiveness in Space (AES-1) consists of Commercial Generic Bioprocessing Apparatus and 16 Group Activation Packs. Here, astronaut Mark Kelly works with similar hardware used in the NLP-Vaccine-10 investigation.

Credit: BioServe Space Technologies

Usage Restrictions: Image Credit: BioServe Space Technologies

Related news release: New science bound for station on Orbital's Cygnus


[ Back to EurekAlert! ]